CMS’s efforts to expand Medicare coverage of GLP-1s for obesity could provide substantial benefits to millions of Medicare beneficiaries, given the potential demand for these highly effective medications…There are potential drawbacks to the short-term program, however.
What Medicare’s Temporary Program Covering GLP-1s for Obesity Means for Beneficiaries
March 10, 2026
·
1 min read
·
by Ohio Medicare Planning